Work

Enhanced antitumor activity of erlotinib in combination with quinacrine in EGFR WT and L858R/T790M mutant NSCLC.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.e22153

Authors: Josephine Kam Tai Dermawan, John Pink, Afshin Dowlati, Sarmishtha De, Goutham Narla, George R. Stark, Neelesh Sharma

Institutions: Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Case Western Reserve University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2742840295

Cites:

Cited by:

Related to: 10